U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C18H21N
Molecular Weight 251.366
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DESOXYPIPRADROL

SMILES

C1CCC(NC1)C(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=RWTNXJXZVGHMGI-UHFFFAOYSA-N
InChI=1S/C18H21N/c1-3-9-15(10-4-1)18(16-11-5-2-6-12-16)17-13-7-8-14-19-17/h1-6,9-12,17-19H,7-8,13-14H2

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
32.0 nM [Ki]
213.0 nM [Ki]
PubMed

PubMed

TitleDatePubMed
Inhibition of insulin synthesis by cyproheptadine: effects on translation.
2004 Jun
Patents
Name Type Language
DESOXYPIPRADROL
Common Name English
2-DIPHENYLMETHYLPIPERIDINE [HSDB]
Common Name English
PIPERIDINE, 2-(DIPHENYLMETHYL)-
Systematic Name English
(±)-DESOXYPIPRADROL
Common Name English
DEOXYPIPRADOL
Common Name English
2-(DIPHENYLMETHYL)PIPERIDINE
Systematic Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-Desoxypipradrol
Created by admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
Code System Code Type Description
FDA UNII
49UNK1BV8T
Created by admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
PRIMARY
ECHA (EC/EINECS)
208-276-6
Created by admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
PRIMARY
EPA CompTox
DTXSID90897502
Created by admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
PRIMARY
CAS
519-74-4
Created by admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
PRIMARY
HSDB
8015
Created by admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
PRIMARY
PUBCHEM
160506
Created by admin on Sat Dec 16 08:23:53 GMT 2023 , Edited by admin on Sat Dec 16 08:23:53 GMT 2023
PRIMARY